Medline, Inc. Class A (MDLN)
NASDAQ:MDLN
MDLN Stock Chart & Stats
$43.59
--
Market closed
$43.59
--
Day’s Range― - ―
52-Week Range$34.89 - $50.88
Previous CloseN/A
VolumeN/A
Average Volume (3M)8.01M
Market Cap
$59.90B
Enterprise Value$47.63B
Total Cash (Recent Filing)$1.94B
Total Debt (Recent Filing)$12.56B
Price to Earnings (P/E)29.4
Beta1.92
Next Earnings
May 06, 2026EPS Estimate
0.3Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.23
Shares Outstanding811,647,500
10 Day Avg. Volume6,618,590
30 Day Avg. Volume8,005,576
Financial Highlights & Ratios
PEG Ratio-4.97
Price to Book (P/B)3.18
Price to Sales (P/S)1.20
P/FCF Ratio19.56
Enterprise Value/Market Cap0.80
Enterprise Value/Revenue1.68
Enterprise Value/Gross Profit6.81
Enterprise Value/Ebitda15.33
Forecast
1Y Price Target
$53.71Price Target Upside23.22% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering23
EPS Forecast (FY)1.47
Revenue Forecast (FY)$30.91B
Bulls Say, Bears Say
Bulls Say
Recurring Revenue / ScaleMedline's core model of long-term contracts with hospitals and participation in GPOs creates recurring replenishment demand and high customer retention. Combined with a broad consumables portfolio and national distribution, this structural demand base supports steady revenue and predictable order flows over months to years.
Improving Gross MarginA multi-point improvement in gross margin alongside strong revenue scaling indicates durable improvements in pricing, mix toward higher-margin private-label consumables, or cost control. Sustained gross margin expansion enhances the firm’s ability to absorb SG&A and invest in logistics, supporting longer-term profitability resilience.
Solid Cash GenerationConsistent operating cash flow and a material improvement in free cash flow conversion in 2025 provide durable internal funding for working capital, capex, and debt service. Reliable cash generation increases financial flexibility to support distribution investments and gradual deleveraging over multiple quarters.
Bears Say
Elevated LeverageLeverage near or above parity reduces balance sheet flexibility and increases refinancing and covenant risk if conditions deteriorate. Higher debt limits the company's capacity to pursue M&A or large investments without additional capital actions, making operational execution and cash generation more critical over the medium term.
Margin VolatilityDespite gross margin gains, net and operating margin volatility shows that revenue growth has not consistently translated into incremental profit. Persistent volatility can compress free cash flow and undermine return stability, complicating planning for reinvestment and debt reduction over the coming quarters.
Earnings-to-Cash QualityCoverage of net income by operating cash flow below 100% suggests working-capital swings or non-cash earnings items affecting reported profits. This inconsistency reduces earnings quality and makes forecasting cash available for debt repayment or capex less reliable across multiple reporting periods.
Medline News
MDLN FAQ
What was Medline, Inc. Class A’s price range in the past 12 months?
Medline, Inc. Class A lowest stock price was $34.89 and its highest was $50.88 in the past 12 months.
What is Medline, Inc. Class A’s market cap?
Medline, Inc. Class A’s market cap is $59.90B.
When is Medline, Inc. Class A’s upcoming earnings report date?
Medline, Inc. Class A’s upcoming earnings report date is May 06, 2026 which is in 23 days.
How were Medline, Inc. Class A’s earnings last quarter?
Medline, Inc. Class A released its earnings results on Feb 25, 2026. The company reported $0.225 earnings per share for the quarter, missing the consensus estimate of $0.238 by -$0.013.
Is Medline, Inc. Class A overvalued?
According to Wall Street analysts Medline, Inc. Class A’s price is currently Undervalued.
Does Medline, Inc. Class A pay dividends?
Medline, Inc. Class A does not currently pay dividends.
What is Medline, Inc. Class A’s EPS estimate?
Medline, Inc. Class A’s EPS estimate is 0.3.
How many shares outstanding does Medline, Inc. Class A have?
Medline, Inc. Class A has 811,647,500 shares outstanding.
What happened to Medline, Inc. Class A’s price movement after its last earnings report?
Medline, Inc. Class A reported an EPS of $0.225 in its last earnings report, missing expectations of $0.238. Following the earnings report the stock price went down -3.621%.
Which hedge fund is a major shareholder of Medline, Inc. Class A?
Currently, no hedge funds are holding shares in MDLN
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Medline Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$53.71 (23.22% Upside)
$53.71 (23.22% Upside)
Blogger Sentiment
Bullish
MDLN Sentiment 70%
Sector Average ―
Sector Average ―
Insider Transactions
Sold Shares
Worth $7.6B over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.3%
Last 30 Days ▼ 7.7%
Last 30 Days ▼ 7.7%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Fundamentals
Return on Equity
7.59%
Trailing 12-Months
Asset Growth
6.97%
Trailing 12-Months
Company Description
Medline, Inc. Class A
Medline Inc. manufactures med-surg products serving the hospital, surgery centers, physician offices, post-acute facilities, and nursing home sites of care in the United States and Internationally. It operates through two segments: Medline Brand and Supply Chain Solutions. The Medline Brand segment procures and manufactures products from three product categories include surgical solutions, front line care, and laboratory and diagnostics. Its front line care offers med-surg products for patient-facing needs, including wound care products, exam gloves, skin care and incontinence products, environment cleaning supplies, textiles, hand sanitizer, durable medical equipment, patient plastics, and decolonization and infection control products. Its surgical solutions provide operating room and perioperative environment product solutions, including surgical procedure trays, drapes and gowns, personal protective equipment, sterile wraps, surgical instruments, surgeon's gloves, procedure kits, and orthopedic implants. Its laboratory and diagnostics offer laboratory and diagnostic product solutions, including point of care testing, analyzers and instrumentation, lab and diagnostic consumables, diagnostic instruments, vital signs monitors, and anatomic pathology and phlebotomy products. It provides its products to domestic and international consumers. The Supply Chain Solutions segment procures and distributes a variety of third-party products from national brands. It provides logistics and supply chain optimization services to domestic and international consumers. It also provides supply chain optimization services such as, consulting engagements, outsourced warehouse and technology management, put-away-ready packaging, third-party logistics, inventory rationalization, and route planning. Medline Inc. was founded in 1966 and is based in Northfield, Illinois.
MDLN Company Deck
MDLN Earnings Call
Q4 2026
0:00 / 0:00
MDLN Stock 12 Month Forecast
Average Price Target
$53.71
▲(23.22% Upside)
Baxter International
―
Becton Dickinson
―
ICU Medical
―
Merit Medical Systems
―
Teleflex
―